Sopino, Vicente C.
HRN: 11-26-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/15/2022
11/25/2022
IVT
1.5 G Ivt
Q6 X 4 Days More
Nonhealing Wound, Multiple Myeloma
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes